> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Welldoc 510(k) for BlueStar Insulin Adjustment
- URL: https://www.fdaweb.com/welldoc-510-k-for-bluestar-insulin-adjustment/
- Published: 2020-06-03T12:00:00.000Z
- Updated: 2026-09-14T16:16:59.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5146920

FDA has cleared a Welldoc 510(k) to add a new feature to its digital health product BlueStar Rx which supports individuals using long-acting insulin. The Insulin Adjustment Program (IAP) supports the process of basal insulin titration by health care providers for adults with Type 2 diabetes, according to the company. Patients can integrate BlueStar with any blood glucose monitor, blood pressure cuff, or fitness tracker, it says, adding that the device delivers tailored, real-time feedback to improve long-term diabetes health. It also aggregates critical data to assist by delivering actionable insights to the user’s care team, Welldoc says.